Buhlmann Diagnostics Corp Archives - Page 2 of 3 - Buhlmann Diagnostics Corp

Category: Buhlmann Diagnostics Corp

BUHLMANN LabSense News: Fall 2016 Edition

BUHLMANN Diagnostics Corp is proud to present the very first edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News.  Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this
Continue Reading

Special Pricing on Select Allergens, Assays, and Assay Components

Limited time offer Contact BUHMANN Today for More Details!
Continue Reading

Connect with us at AMLI 2016!

When: August 14-17, 2016 Where:PITTSBURGH, PA Booth: #14 Learn More: AMLI 2016
Continue Reading

BÜHLMANN CAST® Drug Allergens: New Products

We are pleased to announce 2 new BÜHLMANN CAST® Drug Allergens: Tramadol and Metoprolol In order to meet the needs of your Cellular Allergy testing, we are offering an extended allergen portfolio by enriching this product line with new Analgesic and Beta Blocker allergens. Tramadol and Metroprolol are for Research Use Only.  Not for use in diagnostic procedures.
Continue Reading

Flow CAST® eBook- Kinase Inhibition Assay for BTK, SYK, and PI3K Activity

Flow CAST® eBook Testing Potency and Efficacy of Inhibitors of PI3K, PI3K, BTK and SYK Activity Biomarker assays are developed specifically for pharmacokinetic and pharmacodyamic (PK/PD) models during drug discovery and are often used to test efficacy and toxicity. Inhibitors of PI3K, SYK and BTK pathways are a large focus for pharmaceutical companies with several
Continue Reading

Visit BUHLMANN Diagnostics Corp at AACC 2016

When: July 31 - August 4, 2016 Where: Philadelphia, PA Booth: #4202 Learn More: AACC 2016
Continue Reading

Connect with BUHLMANN Diagnostics Corp at MGCC 2016!

When: June 18 - 22, 2016 Where: Edmonton, AB Canada Booth: #307   More Information: Joint Conference of the Canadian College of Medical Geneticists and the Canadian Society of Clinical Chemists (MGCC 2016)
Continue Reading

Testing Potency and Efficacy of Inhibitors of P13K, SYK, BTK Activity

The Flow CAST® is intended for the determination of basophil activation in whole blood samples by flow cytometry. Our unique marker combination – CCR3 and CD63 – combines the simple gating properties for basophil detection by CCR3 with the solid application of the proven activation marker CD63 in one. Thanks to its easy protocol and smart
Continue Reading

New Health Canada License for BÜHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo Speed, Quality and Flexibility in Calprotectin Quantification BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that its innovative product, BÜHLMANN fCAL® turbo, has received a Medical Device License from Health Canada and is now commercially available in Canada.  The device was approved as a Class 2
Continue Reading

Connect with BUHLMANN Diagnostics Corp (BDC) at DDW 2016

When: May 21-24, 2016 Where: San Diego, California Booth: #4155 More Information: Digestive Disease Week (DDW) 2016
Continue Reading